A robust, clinical-trial and publication evidence base supports use of the OrganOx metra®

To date, hundreds of donor livers have been studied in normothermic machine perfusion trials around the world, including 220 livers that formed the Consortium for Organ Preservation in Europe (COPE) randomised controlled trial published in Nature in April 2018.1 With clinical trials taking place across Europe and North America, the metra has an extensive evidence base.

Key trials and publications are summarised below.


Want to know more about the metra?

If you would like to know more about the metra and how it may benefit your liver transplantation unit, click ‘Contact Us’ and a member of the OrganOx team will be in touch.

Contact US

UK/US MD-040-13-1 - September 2022